Teradyne Inc
TER: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| b&# | LOCK|p$ | LOCK|v?Nt<H |
Teradyne Earnings: A Positive Outlook for 2025 and Beyond Matches Our Long-Term Recovery Thesis
Teradyne's fourth-quarter sales rose 12% year over year and 2% sequentially to $753 million. Management guided to mid-teens revenue growth in the first quarter and 2025 and provided a new long-term model including a midpoint target of 15% revenue growth through 2028.
